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Late stent thrombosis (LST) which is a life threatening complication has emerged 
as a serious problem of drug-eluting stents (DES). Several studies have suggested 
that incomplete neointimal coverage of stent struts contributes to LST. Progressive 
atherosclerosis within the neointima is an another possible cause of LST, but this 
phenomenon has seldom been reported in DES. We present a case of LST follow-
ing DES implantation after a period of 28 months due to ruptured atheromatous 
plaque, despite complete neointimal coverage of stent struts proven by optical co-
herence tomography. 
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INTRODUCTION
Drug eluting stent (DES) has successfully been introduced to interventional cardi-
ology in order to prevent in-stent restenosis. Nevertheless, concerns about the safe-
ty of DES still exist. Especially, late stent thrombosis (LST) is an unsolved prob-
lem in the DES era, which was rarely seen with bare metal stents (BMS).1 The risk 
of LST is associated with patient and lesion characteristics, non-compliance of an-
ti-platelet drugs and incomplete stent apposition, number and the length of stents, 
coronary dissection, etc.2,3 Incomplete neointimal coverage of stent struts is the 
most important predictor of LST.4,5 We report a case of LST despite complete neo-
intimal coverage on well-opposed stent struts and continued dual-antiplatelet ther-
apy more than 1 year. 
CASE REPORT 
A 57-year-old male with a history of hypertension, diabetes mellitus, normal renal 
function and a 60 pack years smoking received percutaneous coronary interven-Ruptured Plaque within Neointima after DES Implantation 
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positive. Therefore, he underwent another follow-up angio-
gram to evaluate silent ischemia in January 2010. The fol-
low-up angiogram revealed 2 patent stents implanted in the 
right coronary artery. However, abnormal contrast filling 
tion at the right coronary artery with the impression of stable 
angina pectoris in September 2007 (Fig. 1). Two sirolimus-
eluting stents (SES) [3.0×28 mm, 2.75×28 mm (Cypher, 
Cordis Corp., Johnson & Johnson Co., Warren, New Jersey, 
USA)] were implanted at the distal part of the right coronary 
artery. Transthoracic echocardiography demonstrated normal 
left ventricular systolic function (ejection fraction=56%) with 
regional wall motion abnormality at the inferior wall. One-
year follow-up angiogram showed that 2 stents were all 
patent. Intravascular ultrasound (IVUS) and optical coher-
ence tomography (OCT) revealed complete neointimal 
coverage of stent struts (Fig. 2). 
Until recently, he had good compliance with dual anti-
platelet agents and other medications, and did not suffer 
from chest pain. However, the result of treadmill test was 
Fig. 1. Initial coronary angiogram of the RCA. (A) Coronary angiogram 
shows significant luminal narrowing at the distal RCA. (B) After stent im-





Fig. 3. (A) The 2
nd follow-up angiogram at 28 months after stent implantation shows abnormal contrast filling in a previously implanted 
stent (see arrow). (B, C and D) IVUS and OCT images reveal newly formed and ruptured atheromatous plaque within neointima. 
Arrowheads indicate stent strut. IVUS , intravascular ultrasound; OCT, optical coherence tomography. 
Fig. 2. Coronary angiogram and OCT findings at 12-month follow-up. (A)Coronary angiogram shows no restenosis in the stented segment. 
(B, C and D)The OCT shows complete neointimal coverage of stent struts. OCT, optical coherence tomography.
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curred only after 2 years. We think that early atherosclerosis 
is a possible mechanism in our case. This was an unexpected 
finding and gave us a very helpful insight for better treatment 
and monitoring in patients with DES implantation. 
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defect was observed within the previously stented segments 
(arrow in Fig. 3A). IVUS and OCT were performed to elu-
cidate the characteristics of the abnormal contrast filling de-
fect. Both studies revealed a newly formed and ruptured 
atheromatous plaque within the neointima over the stent 
struts (IVUS and OCT) (Fig. 3B, C and D). He was success-
fully treated with percutaneous coronary intervention and 
discharged on medications of aspirin (100 mg/day), clopi-
dogrel (75 mg/day), atorvastatin (10 mg/day) and atenolol 
(25 mg/day).
DISCUSSION
LST after DES implantation has been thought to be caused 
by poorly formed neointima and incomplete neointimal cov-
erage over DES struts.6 In a recent study using angioscopy, 
however, a newly formed and thrombogenic atherosclerotic 
yellow neointima after DES implantation was reported.7 
This phenomenon may be an another cause for late stent 
thrombosis after DES implantation. Stent thrombosis and 
myocardial infarction caused by restenosis during extended 
follow-up after bare metal stent implantation have been re-
ported and might be explained by newly formed and pro-
gressive atherosclerosis within neointima.8 However, this 
phenomenon has seldom been reported in DES. Atheroscle-
rotic change within neointima after bare metal stent implan-
tation usually occurs after 5 years.7 The intracoronary imag-
es of our patient illustrate a newly formed and ruptured 
atheromatous plaque within neointima after DES implanta-
tion in a relatively short period (less than 3 years after DES 
implantation). A recent pathologic study showed that ath-
erosclerotic lesions progress more rapidly within SES than 
within BMS. In the autopsy study by Nakazawa, et al.9 the 
atherosclerotic change in SES was seen in more than 40 
percent of cases by 9 months, but the change in BMS oc-